The primary end point was the 4-week exhaled carbon monoxide-confirmed continuous abstinence rate for weeks 9 through 12 of treatment , ie , the proportion of participants able to maintain complete abstinence from smoking for the last 4 weeks of treatment , as assessed using multiple imputation analysis .